EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access · CC BY-NC 4.0

Exposure to pseudoephedrine during pregnancy and major congenital malformations: Findings from a large population‐based cohort of pregnancies

Saar Dor iD, Tal Michael, Yael Levi iD, Gali Pariente, Eitan Lunenfeld, Amalia Levy, Shira Birenstock-Cohen, Sharon Daniel iD

British Journal of Clinical Pharmacology · 2025-06 · 91 (6) · 1834-1841

DOI: 10.1002/bcp.70001 ↗

At a glance

Beobachtungsstudie in British Journal of Clinical Pharmacology, published online on 2025-02-16. Written by Saar Dor and 7 co-authors. Institution: Department of Epidemiology, Biostatistics, and Community Health Sciences, School of Public Health, Ben-Gurion University of the Negev, Beer-Sheva, Is…. Major MEDLINE topics: Abnormalities, Drug-Induced, Pseudoephedrine, Tocolytic Agents. Cited 3 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

The aim of this study was to assess the risk of major congenital malformations following first‐trimester pseudoephedrine (PSE) exposure.

Methods

A population‐based observational cohort study was conducted on pregnancies of women aged 15–49 years, insured by Clalit Health Services in southern Israel, who gave birth or had elective pregnancy terminations due to suspected fetal malformation at Soroka Medical Center (1999–2017). The study focused on Clarinase, a drug that contains a high dose of PSE (120 mg) and 5 mg of loratadine. Multivariable negative binomial regression models were used to evaluate the risk for major congenital malformations, adjusting for potential confounders.

Results

Of 251 543 pregnancies, 313 (0.12%) were exposed to high‐dose PSE in the first trimester. PSE exposure was not associated with major congenital malformations overall (adjusted relative risk [aRR] = 0.90, 95% confidence interval [CI] 0.558–1.45; P = 0.66) or by organ system (cardiovascular: aRR = 0.938, 95% CI 0.499–1.762; central nervous system: aRR = 0.618, 95% CI 0.086–4.451; musculoskeletal: aRR = 1.800, 95% CI 0.801–4.042; gastrointestinal: aRR = 1.013, 95% CI 0.142–7.241; genitourinary: aRR = 0.704, 95% CI 0.225–2.204).

Conclusions

First‐trimester PSE exposure was not an independent risk factor for major congenital malformations, either overall or by organ system.

Subjects

MeSH terms (MEDLINE)

Abnormalities, Drug-InducedPseudoephedrineTocolytic AgentsHumansFemalePregnancyAdultAdolescentIsraelYoung AdultMiddle AgedPregnancy Trimester, FirstCohort StudiesRisk Factors

Author keywords

Clarinasecongenital malformationspregnancypseudoephedrine

Substances

PseudoephedrineTocolytic Agents

Authors and institutions

  • Department of Epidemiology, Biostatistics, and Community Health Sciences, School of Public Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Obstetrics and Gynecology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Adelson School of Medicine, Ariel University, Ariel, Israel.
  • Department of Social Services, Soroka University Medical Center, Beer Sheva, Israel.
  • Department of Pediatrics, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Clalit Health Services, Southern District, Beer-Sheva, Israel.

ORCID profiles: Saar Dor, Yael Levi, Sharon Daniel

Cite

APA

Dor, S., Michael, T., Levi, Y., Pariente, G., Lunenfeld, E., Levy, A., Birenstock-Cohen, S., & Daniel, S. (2025). Exposure to pseudoephedrine during pregnancy and major congenital malformations: Findings from a large population‐based cohort of pregnancies. British Journal of Clinical Pharmacology, 91(6), 1834-1841. https://doi.org/10.1002/bcp.70001

Vancouver

Dor S, Michael T, Levi Y, Pariente G, Lunenfeld E, Levy A, et al. Exposure to pseudoephedrine during pregnancy and major congenital malformations: Findings from a large population‐based cohort of pregnancies. British Journal of Clinical Pharmacology. 2025;91(6):1834-1841. doi:10.1002/bcp.70001

BibTeX
@article{Dor2025,
  author = {Dor, Saar and Michael, Tal and Levi, Yael and Pariente, Gali and Lunenfeld, Eitan and Levy, Amalia and Birenstock-Cohen, Shira and Daniel, Sharon},
  title = {Exposure to pseudoephedrine during pregnancy and major congenital malformations: Findings from a large population‐based cohort of pregnancies},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  volume = {91},
  number = {6},
  pages = {1834--1841},
  doi = {10.1002/bcp.70001}
}
Start for free →